By expenditures
| Name | Title | Type |
|---|---|---|
| Rebecca Hoover | Interim Cfo | Auditee |
| Tonya Walker | Cfo | Auditee |
| Reginald Amerson | Associate Vice President of Finance | Auditee |
| Norman Jones | VICE PRESIDENT OF FINANCE/CFO | Auditee |
| Jennifer Manternach | Audit Principal | Auditee |
| David Hunt | PRINCIPAL | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 407740 | 2025 | 2026-07-23 | CROSSLIN PLLC | $23.12M |
| 404057 | 2025 | 2026-06-18 | CROSSLIN PLLC | $23.12M |
| 355168 | 2024 | 2025-04-30 | Crosslin PLLC | $20.81M |
| 348890 | 2023 | 2025-03-27 | Crosslin PLLC | $24.93M |
| 32261 | 2022 | 2023-01-03 | Crosslin PLLC | $21.15M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 407740 | 2025 | 2026-07-23 | 1224472 | 2025-001 | Material Weakness | Yes | A |
| 407740 | 2025 | 2026-07-23 | 1224471 | 2025-001 | Material Weakness | Yes | A |
| 407740 | 2025 | 2026-07-23 | 1224470 | 2025-001 | Material Weakness | Yes | A |
| 407740 | 2025 | 2026-07-23 | 1224469 | 2025-002 | Material Weakness | Yes | A |
| 407740 | 2025 | 2026-07-23 | 1224468 | 2025-003 | Material Weakness | Yes | H |
| 407740 | 2025 | 2026-07-23 | 1224467 | 2025-002 | Material Weakness | Yes | A |
| 407740 | 2025 | 2026-07-23 | 1224466 | 2025-001 | Material Weakness | Yes | A |
| 404057 | 2025 | 2026-06-18 | 1217923 | 2025-001 | Material Weakness | Yes | A |
| 404057 | 2025 | 2026-06-18 | 1217922 | 2025-001 | Material Weakness | Yes | A |
| 404057 | 2025 | 2026-06-18 | 1217921 | 2025-001 | Material Weakness | Yes | A |
| 404057 | 2025 | 2026-06-18 | 1217920 | 2025-002 | Material Weakness | Yes | A |
| 404057 | 2025 | 2026-06-18 | 1217919 | 2025-003 | Material Weakness | Yes | H |
| 404057 | 2025 | 2026-06-18 | 1217918 | 2025-002 | Material Weakness | Yes | A |
| 404057 | 2025 | 2026-06-18 | 1217917 | 2025-001 | Material Weakness | Yes | A |
| 355168 | 2024 | 2025-04-30 | 1135387 | 2024-002 | Significant Deficiency | - | J |
| 355168 | 2024 | 2025-04-30 | 1135386 | 2024-002 | Significant Deficiency | - | J |
| 355168 | 2024 | 2025-04-30 | 1135385 | 2024-002 | Significant Deficiency | - | J |
| 355168 | 2024 | 2025-04-30 | 1135384 | 2024-002 | Significant Deficiency | - | J |
| 355168 | 2024 | 2025-04-30 | 1135383 | 2024-002 | Significant Deficiency | - | J |
| 355168 | 2024 | 2025-04-30 | 1135382 | 2024-001 | Significant Deficiency | - | C |
| 355168 | 2024 | 2025-04-30 | 1135381 | 2024-001 | Significant Deficiency | - | C |
| 355168 | 2024 | 2025-04-30 | 1135380 | 2024-001 | Significant Deficiency | - | C |
| 355168 | 2024 | 2025-04-30 | 1135379 | 2024-001 | Significant Deficiency | - | C |
| 355168 | 2024 | 2025-04-30 | 1135378 | 2024-001 | Significant Deficiency | - | C |
| 355168 | 2024 | 2025-04-30 | 558945 | 2024-002 | Significant Deficiency | - | J |
| 355168 | 2024 | 2025-04-30 | 558944 | 2024-002 | Significant Deficiency | - | J |
| 355168 | 2024 | 2025-04-30 | 558943 | 2024-002 | Significant Deficiency | - | J |
| 355168 | 2024 | 2025-04-30 | 558942 | 2024-002 | Significant Deficiency | - | J |
| 355168 | 2024 | 2025-04-30 | 558941 | 2024-002 | Significant Deficiency | - | J |
| 355168 | 2024 | 2025-04-30 | 558940 | 2024-001 | Significant Deficiency | - | C |
| 355168 | 2024 | 2025-04-30 | 558939 | 2024-001 | Significant Deficiency | - | C |
| 355168 | 2024 | 2025-04-30 | 558938 | 2024-001 | Significant Deficiency | - | C |
| 355168 | 2024 | 2025-04-30 | 558937 | 2024-001 | Significant Deficiency | - | C |
| 355168 | 2024 | 2025-04-30 | 558936 | 2024-001 | Significant Deficiency | - | C |
| 32261 | 2022 | 2023-01-03 | 606279 | 2022-002 | - | Yes | L |
| 32261 | 2022 | 2023-01-03 | 606278 | 2022-001 | Significant Deficiency | - | C |
| 32261 | 2022 | 2023-01-03 | 29837 | 2022-002 | - | Yes | L |
| 32261 | 2022 | 2023-01-03 | 29836 | 2022-001 | Significant Deficiency | - | C |